Finance

Lists
002772:SHE
Tianshui Zhongxing Bio-technology Co Ltd
CN¥7.83
+1.82%
(+0.14) 1D
Nov 4, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002772...
Open
CN¥7.66
High
CN¥7.83
Low
CN¥7.60
Mkt. cap
2.88B
Avg. vol.
9.83M
Volume
12.27M
Dividend
6.39%
Quarterly dividend
CN¥0.12
Ex-dividend date
Oct 14, 2026
P/E ratio
13.94
52-wk high
CN¥19.73
52-wk low
CN¥7.50
EPS
CN¥0.56
Shares outstanding
375.44M
No. of employees
9K
Open
CN¥7.66
High
CN¥7.83
Low
CN¥7.60
Mkt. cap
2.88B
Avg. vol.
9.83M
Volume
12.27M
Dividend
6.39%
Quarterly dividend
CN¥0.12
Ex-dividend date
Oct 14, 2026
P/E ratio
13.94
52-wk high
CN¥19.73
52-wk low
CN¥7.50
EPS
CN¥0.56
Shares outstanding
375.44M
No. of employees
9K
News stories
From web sources and news partners
About Tianshui Zhongxing Bio-technology Co Ltd
CEO-
Employees9.18K
FoundedNov 18, 2005
Headquarters-
SectorFood
Industry-
Websitetszxjy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
622.98M
601.97M
483.38M
519.30M
Cost of goods sold
395.22M
365.10M
387.64M
439.40M
Cost of revenue
395.22M
365.10M
387.64M
439.40M
Research and development expenses
6.52M
2.59M
3.11M
2.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
84.05M
60.15M
66.15M
58.77M
Operating expense
109.07M
63.46M
57.35M
77.31M
Total operating expenses
504.28M
428.56M
444.99M
516.71M
Operating income
118.69M
173.41M
38.40M
2.59M
Other non operating income
-8.09M
-3.31M
3.38M
-8.14M
EBT including unusual items
132.01M
163.34M
27.70M
-107.47M
EBT excluding unusual items
108.65M
162.37M
24.28M
-10.53M
Income tax expense
1.21M
-
-
-
Effective tax rate
0.91%
-
-
-
Other operating expenses
17.66M
643.34K
-11.38M
13.93M
Net income
130.62M
162.70M
28.15M
-106.80M
Net profit margin
20.97%
27.03%
5.82%
-20.57%
Earnings per share
-
-
-
-
Interest and investment income
7.90M
6.88M
7.93M
6.88M
Interest expense
-15.75M
-14.61M
-18.99M
-18.30M
Net interest expenses
-7.85M
-7.74M
-11.06M
-11.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
196.62M
251.34M
103.05M
80.51M
Gain or loss from assets sale
6.54M
-
6.00M
-6.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps